- Exchange: New York
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Medical-Drugs
Bristol-Myers Squibb Co
+ Add to WatchlistBMY:US
43.7600 USD 0.4600 1.06%
Share
As of 16:15:06 ET on 05/20/2013.
More on BMY
News for Bristol-Myers Squibb Co (BMY)
-
COMPANY NEWS
-
PRESS RELEASES
-
INDUSTRY NEWS
- Bristol-Myers Drug Cocktail Stymies Melanoma Tumors
- U.S. Stock Options With Biggest Changes in Implied Volatility
- Bristol-Myers Targets Heart-Failure Drugs in R&D Effort
- Primecap Rides Health to Top Growth Fund: Riskless Return
- Human Immune-Boosting Cancer Drugs Seen Extending Lives
- Boston Scientific’s Mahoney Says Watchman Key to Growth
- Bristol-Myers, Disney, Google: Intellectual Property
- Bristol-Myers Sues Genentech Over ‘Cabilly’ Patents
- Half of Hepatitis C Patients Don’t Get Full Testing, CDC Says
- Gilead Rises To Highest Price on Potential Drug Sales
- Gilead’s Hepatitis C Treatment Clears Virus in Eight Weeks
- Merck Cuts Profit Forecast as Buyback Boosted $15 Billion
- Novo Nordisk First-Quarter Profit Climbs on Insulins, Victoza
- Pfizer Lowers 2013 Forecast After Sales Miss Estimates
- Gilead Fails FDA Approval for 2 HIV Drugs in 4-in-1 Pill
- ConvaTec Announces 2013 First Quarter Earnings Call Published May 17, 2013
- Bristol-Myers Squibb Announces Intention to Voluntarily Delist Preferred Stock Published May 16, 2013
- Bristol-Myers Squibb to Hold Investor Teleconference to Discuss ASCO Highlights Published May 15, 2013
- Bristol-Myers Squibb Advances Leadership Position in Immuno-Oncology with Data to be Presented at 2013 American Society of Published May 15, 2013
- ALM's Corporate Counsel Names "Best Legal Departments" Winners: Acorda Therapeutics, Bristol-Myers Squibb, Caesars, California Published May 15, 2013
- Preliminary Study Results Find 47 Percent Fewer Complications, Higher Patient Satisfaction with AQUACEL® Ag SURGICAL Cover Published May 15, 2013
- Bristol-Myers Squibb to Present at UBS Global Health Care Conference Published May 14, 2013
- Nuvilex, Inc.'s Dr. Gerald Crabtree Discusses Upcoming Phase III Cancer Trials, Fast Track and Orphan Drug Status Published May 13, 2013
- Adaptive Biotechnologies Signs Biomarker Discovery Collaboration Agreement with Bristol-Myers Squibb Published May 09, 2013
- Bristol-Myers Squibb to Present at Bank of America Merrill Lynch Health Care Conference Published May 08, 2013
- Bristol-Myers Squibb and Pfizer Announce Publication of ARISTOTLE Subanalysis in Circulation Published May 07, 2013
- AstraZeneca and Bristol–Myers Squibb Receive Award from Major Medical Association Published May 07, 2013
- The Zacks Analyst Blog Highlights: Bristol-Myers Squibb, Sanofi, AbbVie, Celgene and Telus Published May 07, 2013
- Sub-Group Analysis Shows Investigational Metreleptin Treatment Demonstrated Reductions in HbA1c, Triglycerides and Liver Published May 06, 2013
- Ambrx Initiates Collaboration with Bristol-Myers Squibb for Discovery, Development of Next-Generation Antibody Drug Conjugates Published May 03, 2013
- Actavis to Buy Warner Chilcott in Women’s Health Effort Updated 1 hour ago
- Royalty Pharma Raises Elan Bid to $12.50 a Share in Cash Updated 1 hour ago
- Vitamins That Cost Pennies a Day Seen Delaying Dementia Updated 2 hours ago
- XenoPort Sinks as Spasticity Drug For MS Fails in Trial
- Merck Insomnia Drug Safer at Lower Dose, FDA Staff Says
- ‘Love Hormone’ Promises Safer Births After Pfizer Flop
- Elan Makes Two Acquisitions for $380 Million
- China’s Stocks Rise to Seven-Week High as Trading Volumes Surge
- Japan Biotech Firms Jump as Abenomics Cash Spurs Speculation
- Lundbeck-Takeda Drug Fights Depression Better at Higher Dose
- SAC Says Cooperation With U.S. No Longer ‘Unconditional’
- Credit Swaps in U.S. Fall as Leading Indicators, Sentiment Rise
- Puma Biotech Gains After Rival Drug Data Show No Threat
- J&J Will Stop Sales of Metal-on-Metal Hip Replacements
- Sanofi, French Government at Odds Over Fate of Research Site
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Advertisements
Advertisement
Rate this Page